Blood Cancer United Secures $562,500 Grant Partnership

The funding supports a five-year initiative focused on patient education and clinical trial outreach in the region.

Updated on Oct. 23, 2026 in Philanthropy

Blood Cancer United Secures $562,500 Grant Partnership

Live Poll

Do you believe local health organizations in your area provide sufficient support for families facing cancer?

Blood Cancer United has been awarded a $562,500 grant partnership spanning five years to expand its patient support services. This initiative, involving the Community Cancer Institute and the California Institute of Regenerative Medicine, aims to enhance education and survivorship resources for patients.

Why it matters

The grant aims to increase awareness of newly emerging cancer therapies and clinical trials, particularly for individuals facing over 100 different types of blood cancers. By fostering collaboration between healthcare institutions, the partnership seeks to bridge gaps in patient outreach.

The five-year grant partnership provides $562,500 in total funding. Blood Cancer United uses these resources to assist patients navigating more than 100 distinct types of blood cancers.

The players

Blood Cancer United

This organization serves individuals with over 100 types of blood cancers by providing clinical trial navigation and financial support.

Alene Mestjian

She serves as the Executive Director of Blood Cancer United.

Community Cancer Institute

This healthcare provider is a partner in the new grant initiative for blood cancer patients.

California Institute of Regenerative Medicine

This organization is a partner in the collaborative grant focused on cancer therapy and education.

The details

The grant supports patient education, survivorship workshops, and outreach initiatives conducted in both English and other languages. Blood Cancer United partners with local healthcare providers and businesses to provide financial assistance and clinical trial navigation services.

2025: CAR-T cell therapy entered hospital trial phases.
November 5, 2026: Winners will be announced at the Philanthropy Excellence Awards.

Market Landscape

This partnership follows a pattern set by the California Institute of Regenerative Medicine for funding patient-focused research and education. It signals a move toward increased clinical integration between regional healthcare providers and specialized nonprofit service organizations.

Local patients will gain improved access to bilingual educational resources and clinical trial guidance. These efforts aim to simplify the navigation process for families managing blood cancer diagnoses.

The takeaway

Patients navigating complex diagnoses can benefit from leveraging institutional partnerships to access clinical trials. Organizations like Blood Cancer United offer specific navigation services that can help individuals identify appropriate therapy options.